Medicines run short in Iran under US sanctions

The US sanctions aimed at isolating Iran have led to a severe shortage of essential medicines in the country. This campaign has made it increasingly difficult for Iranian pharmaceutical companies to source ingredients and technology from abroad, causing a ripple effect in healthcare services. The situation underscores the broader implications of economic sanctions on humanitarian issues, highlighting a critical conflict between political strategies and public health outcomes. For more details, check out the full article in the Financial Times.